Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Hybrids Molecularly Imprinted Polymers: The Future of Nanomedicine?

Version 1 : Received: 28 September 2021 / Approved: 29 September 2021 / Online: 29 September 2021 (14:16:32 CEST)

How to cite: Garnier, M.; Sabbah, M.; Ménager, C.; Griffete, N. Hybrids Molecularly Imprinted Polymers: The Future of Nanomedicine?. Preprints 2021, 2021090496 (doi: 10.20944/preprints202109.0496.v1). Garnier, M.; Sabbah, M.; Ménager, C.; Griffete, N. Hybrids Molecularly Imprinted Polymers: The Future of Nanomedicine?. Preprints 2021, 2021090496 (doi: 10.20944/preprints202109.0496.v1).

Abstract

Molecularly imprinted polymers (MIPs) have been widely used in nanomedicine during the last few years. However, their potential is limited by their intrinsic properties resulting, for instance, in lack of control in drug release processes or complex detection for in vivo imaging. Recent attempts in creating hybrid nanomaterials combining MIPs with inorganic nanomaterials succeeded in providing a wide range of new interesting properties suitable for nanomedicine. Through this review, we aim to illustrate how hybrids molecularly imprinted polymers may improve patient care with enhanced imaging, treatments and combination of both.

Keywords

Nanomedicine; molecularly imprinted polymer; drug delivery; targeting; hybrid material

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.